We are experts in the practise area of intellectual property with a focus on technology law.
Shaun Berg has worked as a lawyer in commercialising biotechnology for the last fifteen years. He has completed national and international transactions for a range of large and small clients in the areas of technological development and software. His experience includes:
Commercialisation of FDA Approved Drug for Marataux Lamy Disease to US Pharmaceutical Company – market exceeding $2B.
Commercialisation of FDA Approved Drug for Hunter Disease to US Pharmaceutical Company – market exceeding $3B.
Commercialisation of new-born screening techniques to a US based institution, including consideration of IP issues, structuring of the licensing deal and supporting documentation – market exceeding $50M per year.
Management of patent portfolio for major public sector research hospital, including decisions to patent, shaping and structuring claims, prosecution and maintenance – number of patents exceeding 100.
Leveraging financial returns from the commercialisation of new technology created by SA Health researchers (exceeding $300M)
Negotiation and Drafting of Production Investment Agreement, Completion Guarantee and other documents for the film ‘Wolf Creek’.
Commercialisation of security application with Symantec including negotiation of term sheet, licensing arrangements and associated contractual arrangements.